3-Hydroxy-2-(1-hydroxy-2-methyl-3-oxopropan-2-yl)oxy-2-methylpropanal

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 3-Hydroxy-2-(1-hydroxy-2-methyl-3-oxopropan-2-yl)oxy-2-methylpropanal
• 英文别名: 3-hydroxy-2-(1-hydroxy-2-methyl-3-oxopropan-2-yl)oxy-2-methylpropanal
• 化学式: C₈H₁₄O₅
• 分子量: 190.19
• InChiKey: MPTQLQRVBWBPPI-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -1.8
• 重原子数：
  13
• 可旋转键数：
  6
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.75
• 拓扑面积：
  83.8
• 氢给体数：
  2
• 氢受体数：
  5

文献信息

• Targeted Therapeutic Nanoparticles
  申请人：nanoDERM Sciences, Inc.

  公开号：US20140199232A1

  公开（公告）日：2014-07-17

  Disclosure of methods and compositions related to chemical conjugations to nanoparticles of polysaccharides cross-linked to poloxamers as well as nano-sized colloids comprised of polysaccharides and poloxamers. The nanoparticles may be produced by various methods including inverse miniemulsion polymerization processes which create nanogels of desired size, shape, and stability for controlled therapeutic drug delivery, imaging, and theragnostic applications.
• TARGETED THERAPEUTIC NANOPARTICLES
  申请人：nanoDERM SCIENCES, INC.

  公开号：US20160106852A1

  公开（公告）日：2016-04-21

  Disclosure of methods and compositions related to chemical conjugations to nanoparticles of polysaccharides cross-linked to poloxamers as well as nano-sized colloids comprised of polysaccharides and poloxamers. The nanoparticles may be produced by various methods including inverse miniemulsion polymerization processes which create nanogels of desired size, shape, and stability for controlled therapeutic drug delivery, imaging, and theragnostic applications.
• US9161962B2
  申请人：——

  公开号：US9161962B2

  公开（公告）日：2015-10-20
• US9694085B2
  申请人：——

  公开号：US9694085B2

  公开（公告）日：2017-07-04